Literature DB >> 30524584

Acute embolic stroke in a patient with atrial fibrillation after electroconvulsive therapy.

Hideaki Suzuki1, Takehisa Takano2, Miya Tominaga2, Kazumasa Suzuki2, Yutaka Kagaya1.   

Abstract

Although patients with atrial fibrillation (AF) have an increased risk of embolic stroke, some clinicians hesitate to provide anticoagulation therapy for these patients during electroconvulsive therapy (ECT), which is widely applied for the treatment of intractable depression, bipolar disorder, and catatonic schizophrenia, because of potential intracerebral hemorrhage. We report on a 77-year-old female depressive patient with AF treated with aspirin but not on anticoagulation therapy because of poor compliance who developed embolic stroke 1 day after the last ECT. The CHADS2 score of this patient was 2 and included the age and hypertension. The present case suggests that anticoagulation therapy should be considered for patients with obvious risks of embolic stroke when they are subjected to ECT.

Entities:  

Keywords:  Anticoagulation; Atrial fibrillation; Electroconvulsive therapy; Stroke

Year:  2010        PMID: 30524584      PMCID: PMC6264972          DOI: 10.1016/j.jccase.2010.01.004

Source DB:  PubMed          Journal:  J Cardiol Cases        ISSN: 1878-5409


  21 in total

1.  Platelet supersensitivity to thrombin stimulation in depression: a possible mechanism for the association with cardiovascular mortality.

Authors:  M Berk; H Plein
Journal:  Clin Neuropharmacol       Date:  2000 Jul-Aug       Impact factor: 1.592

2.  Cardiac arrhythmias induced by ECT in elderly psychiatric patients: experience with 48-hour Holter monitoring.

Authors:  Martti J Huuhka; Lauri Seinelä; Pekka Reinikainen; Esa V J Leinonen
Journal:  J ECT       Date:  2003-03       Impact factor: 3.635

3.  Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation.

Authors:  B F Gage; A D Waterman; W Shannon; M Boechler; M W Rich; M J Radford
Journal:  JAMA       Date:  2001-06-13       Impact factor: 56.272

4.  Atrial fibrillation, failed cardioversion, and electroconvulsive therapy.

Authors:  A Ottaway
Journal:  Anaesth Intensive Care       Date:  2002-04       Impact factor: 1.669

5.  The use of nicardipine for electroconvulsive therapy: a dose-ranging study.

Authors:  Yunan Zhang; Paul F White; Larry Thornton; Lisa Perdue; Michael Downing
Journal:  Anesth Analg       Date:  2005-02       Impact factor: 5.108

6.  Major depression, heart rate, and plasma norepinephrine in patients with coronary heart disease.

Authors:  R M Carney; K E Freedland; R C Veith; P E Cryer; J A Skala; T Lynch; A S Jaffe
Journal:  Biol Psychiatry       Date:  1999-02-15       Impact factor: 13.382

Review 7.  The relationship between depression and cardiovascular disorders.

Authors:  S Malhotra; G E Tesar; K Franco
Journal:  Curr Psychiatry Rep       Date:  2000-06       Impact factor: 5.285

8.  Atrial Fibrillation, Cardioversion, and Electroconvulsive Therapy.

Authors:  Harold H. Harsch
Journal:  Convuls Ther       Date:  1991

Review 9.  Depression as a contributing factor in cerebrovascular disease.

Authors:  K R Krishnan
Journal:  Am Heart J       Date:  2000-10       Impact factor: 4.749

10.  Safety of electroconvulsive therapy in patients receiving long-term warfarin therapy.

Authors:  Vinay Mehta; Paul S Mueller; Heydy L Gonzalez-Arriaza; V Shane Pankratz; Teresa A Rummans
Journal:  Mayo Clin Proc       Date:  2004-11       Impact factor: 7.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.